Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution

Cell Reports

Volumn 12, Issue 5, 2015, Pages 809-820

  Laughney, Ashley M ^a   Elizalde, Sergi ^b   Genovese, Giulio ^c,d   Bakhoum, Samuel F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Dartmouth College   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER CELL; CANCER GENETICS; CELL CLONE; CELL SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION; CLONAL EVOLUTION; CONTROLLED STUDY; DIPLOIDY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; KARYOTYPE EVOLUTION; MOLECULAR DYNAMICS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TETRAPLOIDY; TRIPLOIDY; BIOLOGICAL MODEL; GENE TRANSLOCATION; GENETICS; HUMAN; HUMAN CHROMOSOME; MOLECULAR EVOLUTION; NEOPLASM; PLOIDY;

ABNORMAL KARYOTYPE; CHROMOSOMES, HUMAN; EVOLUTION, MOLECULAR; HUMANS; MODELS, GENETIC; NEOPLASMS; PLOIDIES; TRANSLOCATION, GENETIC;

EID: 84938549838     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.065     Document Type: Article

References (44)

1. Bakhoum S.F., Compton D.A. Chromosomal instability and cancer: a complex relationship with therapeutic potential. J. Clin. Invest. 2012, 122:1138-1143.
2. Bakhoum S.F., Genovese G., Compton D.A. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr. Biol. 2009, 19:1937-1942.
3. Bakhoum S.F., Thompson S.L., Manning A.L., Compton D.A. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat. Cell Biol. 2009, 11:27-35.
4. Bakhoum S.F., Danilova O.V., Kaur P., Levy N.B., Compton D.A. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 2011, 17:7704-7711.
5. Bakhoum S.F., Kabeche L., Murnane J.P., Zaki B.I., Compton D.A. DNA-damage response during mitosis induces whole-chromosome missegregation. Cancer Discov 2014, 4:1281-1289.
6. Bakhoum S.F., Silkworth W.T., Nardi I.K., Nicholson J.M., Compton D.A., Cimini D. The mitotic origin of chromosomal instability. Curr. Biol. 2014, 24:R148-R149.
7. Bakhoum S.F., Kabeche L., Wood M.D., Laucius C.D., Qu D., Laughney A.M., Reynolds G.E., Louie R.J., Phillips J., Chan D.A., et al. Numerical chromosomal instability mediates susceptibility to radiation treatment. Nat. Commun. 2015, 6:5990.
8. Birkbak N.J., Eklund A.C., Li Q., McClelland S.E., Endesfelder D., Tan P., Tan I.B., Richardson A.L., Szallasi Z., Swanton C. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res. 2011, 71:3447-3452.
9. Bozic I., Antal T., Ohtsuki H., Carter H., Kim D., Chen S., Karchin R., Kinzler K.W., Vogelstein B., Nowak M.A. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 2010, 107:18545-18550.
10. Burrell R.A., McClelland S.E., Endesfelder D., Groth P., Weller M.-C., Shaikh N., Domingo E., Kanu N., Dewhurst S.M., Gronroos E., et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 2013, 494:492-496.
11. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 2006, 38:1043-1048.
12. Carter S.L.S., Cibulskis K., Helman E., McKenna A., Shen H., Zack T., Laird P.W.P., Onofrio R.C.R., Winckler W., Weir B.A.B., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 2012, 30:413-421.
13. Chen G., Bradford W.D., Seidel C.W., Li R. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 2012, 482:246-250.
14. Chen G., Mulla W.A., Kucharavy A., Tsai H.-J., Rubinstein B., Conkright J., McCroskey S., Bradford W.D., Weems L., Haug J.S., et al. Targeting the adaptability of heterogeneous aneuploids. Cell 2015, 160:771-784.
15. Crasta K., Ganem N.J., Dagher R., Lantermann A.B., Ivanova E.V.E., Pan Y., Nezi L., Protopopov A., Chowdhury D., Pellman D. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012, 482:53-58.
16. Davoli T., Xu A.W., Mengwasser K.E., Sack L.M., Yoon J.C., Park P.J., Elledge S.J. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 2013, 155:948-962.
17. Dewhurst S.M., McGranahan N., Burrell R.A., Rowan A.J., Grönroos E., Endesfelder D., Joshi T., Mouradov D., Gibbs P., Ward R.L., et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov 2014, 4:175-185.
18. Foijer F., Xie S.Z., Simon J.E., Bakker P.L., Conte N., Davis S.H., Kregel E., Jonkers J., Bradley A., Sorger P.K. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc. Natl. Acad. Sci. USA 2014, 111:13427-13432.
19. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., Martinez P., Matthews N., Stewart A., Tarpey P., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012, 366:883-892.
20. Gorunova L., Höglund M., Andrén-Sandberg A., Dawiskiba S., Jin Y., Mitelman F., Johansson B. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 1998, 23:81-99.
21. Gusev Y., Kagansky V., Dooley W.C. Long-term dynamics of chromosomal instability in cancer: a transition probability model. Math. Comput. Model. 2001, 33:1253-1273.
22. Janssen A., Kops G.J.P.L., Medema R.H. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc. Natl. Acad. Sci. USA 2009, 106:19108-19113.
23. Lee A.J.X., Endesfelder D., Rowan A.J., Walther A., Birkbak N.J., Futreal P.A., Downward J., Szallasi Z., Tomlinson I.P.M., Howell M., et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 2011, 71:1858-1870.
24. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature 1997, 386:623-627.
25. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
26. Pavelka N., Rancati G., Li R. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr. Opin. Cell Biol. 2010, 22:809-815.
27. Pavelka N., Rancati G., Zhu J., Bradford W.D., Saraf A., Florens L., Sanderson B.W., Hattem G.L., Li R. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010, 468:321-325.
28. Rego E.M., Pandolfi P.P. Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?. Trends Mol. Med. 2002, 8:396-405.
29. Roylance R., Endesfelder D., Gorman P., Burrell R.A., Sander J., Tomlinson I., Hanby A.M., Speirs V., Richardson A.L., Birkbak N.J., et al. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2183-2194.
30. Ryan S.D., Britigan E.M.C., Zasadil L.M., Witte K., Audhya A., Roopra A., Weaver B.A. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc. Natl. Acad. Sci. USA 2012, 109:E2205-E2214.
31. Silk A.D., Zasadil L.M., Holland A.J., Vitre B., Cleveland D.W., Weaver B.A. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc. Natl. Acad. Sci. USA 2013, 110:E4134-E4141.
32. Soini Y., Pääkkö P., Lehto V.P. Histopathological evaluation of apoptosis in cancer. Am. J. Pathol. 1998, 153:1041-1053.
33. Sotillo R., Hernando E., Díaz-Rodríguez E., Teruya-Feldstein J., Cordón-Cardo C., Lowe S.W., Benezra R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007, 11:9-23.
34. Stephens P.J., Greenman C.D., Fu B., Yang F., Bignell G.R., Mudie L.J., Pleasance E.D., Lau K.W., Beare D., Stebbings L.A., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
35. Stingele S., Stoehr G., Peplowska K., Cox J., Mann M., Storchova Z. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 2012, 8:608.
36. Tang Y.-C., Williams B.R., Siegel J.J., Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell 2011, 144:499-512.
37. Thompson S.L., Compton D.A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 2008, 180:665-672.
38. Tomasetti C., Vogelstein B., Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA 2013, 110:1999-2004.
39. Upender M.B., Habermann J.K., McShane L.M., Korn E.L., Barrett J.C., Difilippantonio M.J., Ried T. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res. 2004, 64:6941-6949.
40. Valind A., Jin Y., Gisselsson D. Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution. PLoS ONE 2013, 8:e70445.
41. Wang Y., Waters J., Leung M.L., Unruh A., Roh W., Shi X., Chen K., Scheet P., Vattathil S., Liang H., et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014, 512:155-160.
42. Weaver B.A.A., Silk A.D., Montagna C., Verdier-Pinard P., Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007, 11:25-36.
43. Yates L.R., Campbell P.J. Evolution of the cancer genome. Nat. Rev. Genet. 2012, 13:795-806.
44. Zaki B.I., Suriawinata A.A., Eastman A.R., Garner K.M., Bakhoum S.F. Chromosomal instability portends superior response of rectal adenocarcinoma to chemoradiation therapy. Cancer 2014, 120:1733-1742.